The Aurora Funds is among the investors in a $21.5 million Series C venture capital firm for medical device firm CardioFocus.
CardioFocus, which is based in Boston, is developing catheters for use in combating atrial fibrillation, or abnormal heart rhythm.
Chris Kroeger, a principal for Durham-based Aurora, will join the CardioFocus board.
Leading the round were HIG Ventures and KBL Healthcare Ventures. Aurora is a new investor in CardioFocus. Other investors include Accuitive Medical Ventures, Oxford Bioscience Partners and SV Life Sciences.
Aurora Funds: www.aurorafunds.com